The Parkinson's disease death rate: carbidopa and vitamin B6
Marty Hinz,1 Alvin Stein,2 Ted Cole31Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, USA; 2Stein Orthopedic Associates, Plantation, FL, USA; 3Cole Center for Healing, Cincinnati, OH, USAAbstract: The only indication for carbidopa and benserazide is the management of L-3,4-dihydroxyp...
Saved in:
Main Authors: | Hinz M, Stein A, Cole T |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/87d24a3a33724faa8d5da050db49656d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
by: Hinz M, et al.
Published: (2021) -
Parkinson's disease: carbidopa, nausea, and dyskinesia
by: Hinz M, et al.
Published: (2014) -
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
by: Hinz M, et al.
Published: (2020) -
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
by: Hinz M, et al.
Published: (2021) -
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
by: Hinz M, et al.
Published: (2020)